Mitochondrial hydrogen peroxide production by pyruvate dehydrogenase and α-ketoglutarate dehydrogenase in oxidative eustress and oxidative distress
O Chalifoux, B Faerman, RJ Mailloux - Journal of Biological Chemistry, 2023 - ASBMB
Pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase (KGDH) are vital entry
points for monosaccharides and amino acids into the Krebs cycle and thus integral for …
points for monosaccharides and amino acids into the Krebs cycle and thus integral for …
Hypercaloric low-carbohydrate high-fat diet protects against the development of nonalcoholic fatty liver disease in obese mice in contrast to isocaloric Western diet
A Charlot, A Bringolf, J Mallard, AL Charles… - Frontiers in …, 2024 - frontiersin.org
Objective Obesity and metabolic complications, such as type 2 diabetes and nonalcoholic
fatty liver disease (NAFLD), are one of the greatest public health challenges of the 21st …
fatty liver disease (NAFLD), are one of the greatest public health challenges of the 21st …
Brain-specific Gata4 downregulation in Greywick female mice models the metabolic subtype of polycystic ovary syndrome
SA Nawaito, M Esmael, O Souchkova, T Cardinal… - bioRxiv, 2024 - biorxiv.org
Polycystic ovary syndrome (PCOS) is a heterogenous disorder characterized by
reproductive and metabolic abnormalities. PCOS etiology remains poorly understood …
reproductive and metabolic abnormalities. PCOS etiology remains poorly understood …
Hesperidin as a Novel Therapeutic for Metabolic and Hepatic Disturbances in Metabolic Syndrome
A Jamal - 2023 - opal.latrobe.edu.au
Hesperidin as a Novel Therapeutic for Metabolic and Hepatic Disturbances in Metabolic Syndrome
Page 1 1 Hesperidin as a Novel Therapeutic for Metabolic and Hepatic Disturbances in Metabolic …
Page 1 1 Hesperidin as a Novel Therapeutic for Metabolic and Hepatic Disturbances in Metabolic …